| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EQIX | Common Stock | Options Exercise | $0 | +1.66K | +8.66% | $0.00 | 20.8K | Jan 16, 2024 | Direct | |
| transaction | EQIX | Common Stock | Options Exercise | $0 | +1.31K | +6.29% | $0.00 | 22.1K | Jan 16, 2024 | Direct | |
| transaction | EQIX | Common Stock | Options Exercise | $0 | +1.5K | +6.79% | $0.00 | 23.7K | Jan 16, 2024 | Direct | |
| transaction | EQIX | Common Stock | Options Exercise | $0 | +1.78K | +7.54% | $0.00 | 25.4K | Jan 16, 2024 | Direct | |
| transaction | EQIX | Common Stock | Sale | -$79.1K | -100 | -0.39% | $790.96 | 25.3K | Jan 17, 2024 | Direct | F1, F2 |
| transaction | EQIX | Common Stock | Sale | -$496K | -626 | -2.47% | $793.04 | 24.7K | Jan 17, 2024 | Direct | F1, F3 |
| transaction | EQIX | Common Stock | Sale | -$302K | -380 | -1.54% | $794.76 | 24.3K | Jan 17, 2024 | Direct | F1, F4 |
| transaction | EQIX | Common Stock | Sale | -$377K | -474 | -1.95% | $796.12 | 23.9K | Jan 17, 2024 | Direct | F1, F5 |
| transaction | EQIX | Common Stock | Sale | -$159K | -200 | -0.84% | $797.11 | 23.7K | Jan 17, 2024 | Direct | F1, F6 |
| transaction | EQIX | Common Stock | Sale | -$160K | -200 | -0.85% | $801.89 | 23.5K | Jan 17, 2024 | Direct | F1 |
| transaction | EQIX | Common Stock | Sale | -$161K | -200 | -0.85% | $804.98 | 23.3K | Jan 17, 2024 | Direct | F1, F7 |
| transaction | EQIX | Common Stock | Sale | -$80.6K | -100 | -0.43% | $805.75 | 23.2K | Jan 17, 2024 | Direct | F1 |
| transaction | EQIX | Common Stock | Sale | -$323K | -400 | -1.73% | $808.26 | 22.8K | Jan 17, 2024 | Direct | F1, F8 |
| transaction | EQIX | Common Stock | Sale | -$162K | -200 | -0.88% | $809.46 | 22.6K | Jan 17, 2024 | Direct | F1, F9 |
| transaction | EQIX | Common Stock | Sale | -$162K | -200 | -0.89% | $810.59 | 22.4K | Jan 17, 2024 | Direct | F1, F10 |
| transaction | EQIX | Common Stock | Sale | -$163K | -200 | -0.89% | $812.80 | 22.2K | Jan 17, 2024 | Direct | F1, F11 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EQIX | Restricted Stock Units | Award | $0 | +1.66K | $0.00 | 1.66K | Jan 16, 2024 | Common Stock | 1.66K | $0.00 | Direct | F12, F13 | |
| transaction | EQIX | Restricted Stock Units | Options Exercise | $0 | -1.66K | -100% | $0.00* | 0 | Jan 16, 2024 | Common Stock | 1.66K | $0.00 | Direct | F12, F13 |
| transaction | EQIX | Restricted Stock Units | Options Exercise | $0 | -1.31K | -100% | $0.00* | 0 | Jan 16, 2024 | Common Stock | 1.31K | $0.00 | Direct | F13, F14 |
| transaction | EQIX | Restricted Stock Unit | Options Exercise | $0 | -1.5K | -50.02% | $0.00 | 1.5K | Jan 16, 2024 | Common Stock | 1.5K | $0.00 | Direct | F13, F15 |
| transaction | EQIX | Restricted Stock Unit | Options Exercise | $0 | -1.78K | -33.35% | $0.00 | 3.57K | Jan 16, 2024 | Common Stock | 1.78K | $0.00 | Direct | F13, F16 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Shares were sold pursuant to a 10b5-1 Trading Plan in order to raise funds to pay the required withholding tax pursuant to the vesting of RSUs. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $790.95 to $790.97, inclusive. The reporting person undertakes to provide to Equinix, Inc, any security holder of Equinix Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 through 11 to this Form 4. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $792.95 to $793.79 inclusive. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $794.46 to $795.29 inclusive. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $795.84 to $796.69 inclusive. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $797.08 to $797.13 inclusive. |
| F7 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $804.57 to $805.39 inclusive. |
| F8 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $807.89 to $808.47 inclusive. |
| F9 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $809.11 to $809.81 inclusive. |
| F10 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $810.27 to $810.91 inclusive. |
| F11 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $812.61 to $812.99 inclusive. |
| F12 | On February 18, 2021, the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the degree to which a relative Total Shareholder Return target was attained for the period January 1, 2021 to December 31, 2023. The Compensation Committee certified that the payout for this award would be 84.44% (out of a possible 100%) of the target to the reporting person based on the degree to which Equinix performed against the Russell 1000 Index. |
| F13 | Restricted stock unit award expires upon reporting person's termination of service. |
| F14 | Vesting is dependent upon continuous active service as an employee, consultant or director of the Company or a subsidiary of the Company (Service) throughout the vesting period. The Restricted Stock Units shall vest as follows: 33.33% of the RSUs vested on January 15, 2022 and an additional 33.33% of the RSUs will each vest on January 15, 2023 and January 15, 2024. |
| F15 | Vesting is dependent upon continuous active service as an employee, consultant or director of the Company or a subsidiary of the Company (Service) throughout the vesting period. The Restricted Stock Units shall vest as follows: 33.33% of the RSUs vested on January 15, 2023 and an additional 33.33% of the RSUs will each vest on January 15, 2024 and January 15, 2025. |
| F16 | Vesting is dependent upon continuous active service as an employee, consultant or director of the Company or a subsidiary of the Company (Service) throughout the vesting period. The Restricted Stock Units shall vest as follows: 33.33% of the RSUs vested on January 15, 2024 and an additional 33.33% of the RSUs will each vest on January 15, 2025 and January 15, 2026. |